Search This Blog

Thursday, September 17, 2026

Citi upgrades Haemonetics to Buy from Neutral and raises its price target to $123

 citing potential upside from the company’s non-exclusive supply agreement with CSL.

https://finviz.com/stock?t=HAE&p=d

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)